DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Muromonab is an investigational drug.
There have been 10 clinical trials for Muromonab. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2011.
The most common disease conditions in clinical trials are Myelodysplastic Syndromes, Preleukemia, and Leukemia. The leading clinical trial sponsors are National Cancer Institute (NCI), Mayo Clinic, and St. Jude Children's Research Hospital.
There are sixty-one US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for Muromonab
|Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients||Northwestern University||Phase 1|
|Oral OKT3 for the Treatment of Active Ulcerative Colitis||Brigham and Women's Hospital||Phase 1/Phase 2|
|Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA Following Liver Transplantation||Novartis||Phase 4|
Top disease conditions for Muromonab
Top clinical trial sponsors for Muromonab
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Muromonab||See Pricing||Agent for the treatment and or prophylaxis of an autoimmune disease and for the formation of regulatory T cells||AiCuris GmbH & Co. KG (Wuppertal, DE)||See Pricing|
|Muromonab||See Pricing||Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein||CureVac AG (Tubingen, DE)||See Pricing|
|Muromonab||See Pricing||Cyclotides as immunosuppressive agents||Universitatsklinikum Freiburg (Freiburg, DE) Medizinische Universitat Wien (Vienna, AT)||See Pricing|
|Muromonab||See Pricing||Syndecan-2 compositions and methods of use||Orbsen Therapeutics Limited (IE)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|